secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zentalis Pharmaceuticals, Inc. (ZNTL)
CIK:        0001725160
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001725160-24-000140
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Zentalis shareholders elect Blackwell and Kariuki as directors; say-on-pay passes with 59% support
--------------------------------------------------------------------------------

- Kimberly Blackwell received 48,055,584 votes for (78.9%) and Enoch Kariuki 45,008,378 for (73.9%) to Class I director seats.
- Ratification of Ernst & Young as auditor for FY2024 passed nearly unanimously: 66,098,083 for, 5,665 against.
- Advisory say-on-pay resolution approved with 36,128,130 for (59.3%) and 24,729,730 against (40.6%).
- Total shares voted at annual meeting: 66,107,445, representing 93.09% of outstanding common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725160/000172516024000140/0001725160-24-000140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725160/000172516024000140/zntl-20240621.htm
  HTML page:      https://secwatch.observer/filing/0001725160-24-000140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer